Clinical trials: Dermatofibrosarcoma

Dermatofibrosarcoma

Imatinib in Dermatofibrosarcoma Protuberans (DFSP)

• Completed
• Age: 18 years and older
• Phase 1/2

The purpose of this study is to determine whether imatinib is effective in the treatment of primary and recurrent dermatofibrosarcoma protuberans (DFSP).

Trial name

NCT00122473

Testing

Imatinib (Glivec)

Where

4 sites in Germany

Volunteers

30 people

Sponsor

Dermatologic Cooperative Oncology Group